Nwamaka Onyeogo

After I had requestied to reduce my dosage of a schedule stimulant to a lower dosage, the prescriber also reduced my 30-day prescription to a 22-day prescription. Despite my concern that reducing the dosage would already be challenging, she claimed the doses per month reduction at the same time was a DEA regulation, however, I found out it is a preference with the provider wanting to avoid all possibility of a DEA audit rather than patient care. Prescriber also continued to recommend alternative medications that I had tried in the past and had not worked.